Dipika Nandi

805 total citations
14 papers, 647 citations indexed

About

Dipika Nandi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Dipika Nandi has authored 14 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Dipika Nandi's work include Inflammasome and immune disorders (6 papers), interferon and immune responses (4 papers) and Immune cells in cancer (3 papers). Dipika Nandi is often cited by papers focused on Inflammasome and immune disorders (6 papers), interferon and immune responses (4 papers) and Immune cells in cancer (3 papers). Dipika Nandi collaborates with scholars based in United States and India. Dipika Nandi's co-authors include Ashish Kulkarni, Anujan Ramesh, Sahana Kumar, Naval K. Vikram, Anh Hiep Nguyen, Guruprasad R. Medigeshi, Prasenjit Guchhait, Gowtham K. Annarapu, Sudhanshu Vrati and Tulika Seth and has published in prestigious journals such as Advanced Materials, The Journal of Immunology and Biomaterials.

In The Last Decade

Dipika Nandi

14 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dipika Nandi United States 11 363 220 205 117 84 14 647
Brandon M. Johnson United States 10 640 1.8× 128 0.6× 332 1.6× 142 1.2× 155 1.8× 15 924
Husain Attarwala United States 11 131 0.4× 72 0.3× 458 2.2× 117 1.0× 90 1.1× 19 760
Kiyotaka Fujise Japan 17 257 0.7× 123 0.6× 381 1.9× 205 1.8× 33 0.4× 52 963
Sanjay Rathod United States 12 98 0.3× 107 0.5× 140 0.7× 52 0.4× 62 0.7× 26 489
K. Callaghan Australia 6 161 0.4× 104 0.5× 157 0.8× 168 1.4× 29 0.3× 11 572
Lingyu Wei China 17 192 0.5× 114 0.5× 440 2.1× 268 2.3× 44 0.5× 31 955
Chelsey Smith United States 11 87 0.2× 157 0.7× 203 1.0× 26 0.2× 64 0.8× 24 428
Giacomo Diaceri Switzerland 8 236 0.7× 86 0.4× 183 0.9× 50 0.4× 16 0.2× 9 456

Countries citing papers authored by Dipika Nandi

Since Specialization
Citations

This map shows the geographic impact of Dipika Nandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipika Nandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipika Nandi more than expected).

Fields of papers citing papers by Dipika Nandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dipika Nandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipika Nandi. The network helps show where Dipika Nandi may publish in the future.

Co-authorship network of co-authors of Dipika Nandi

This figure shows the co-authorship network connecting the top 25 collaborators of Dipika Nandi. A scholar is included among the top collaborators of Dipika Nandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dipika Nandi. Dipika Nandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nandi, Dipika, et al.. (2024). Nanoparticle-mediated co-delivery of inflammasome inhibitors provides protection against sepsis. Nanoscale. 16(9). 4678–4690. 10 indexed citations
2.
Nandi, Dipika, et al.. (2023). Nanoreporter for Real‐Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced Science. 10(6). e2204900–e2204900. 10 indexed citations
3.
Nandi, Dipika, et al.. (2023). Caspase-1 Responsive Nanoreporter for In Vivo Monitoring of Inflammasome Immunotherapy. ACS Applied Materials & Interfaces. 15(48). 55545–55558. 2 indexed citations
4.
Nandi, Dipika, et al.. (2022). mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency. Biomaterials Science. 10(19). 5566–5582. 28 indexed citations
5.
Nandi, Dipika, et al.. (2021). Imaging Approaches to Monitor Inflammasome Activation. Journal of Molecular Biology. 434(4). 167251–167251. 14 indexed citations
6.
Nandi, Dipika, Jingjing Gao, Ritam Das, et al.. (2021). Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation. ACS Applied Materials & Interfaces. 13(38). 45300–45314. 25 indexed citations
7.
Nguyen, Anh Hiep, Anujan Ramesh, Sahana Kumar, et al.. (2020). Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy. Science Advances. 6(40). 71 indexed citations
8.
Deshpande, Nilesh, et al.. (2020). Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response. Nanotheranostics. 4(3). 156–172. 10 indexed citations
9.
Ramesh, Anujan, et al.. (2020). A Nitric Oxide (NO) Nanoreporter for Noninvasive Real‐Time Imaging of Macrophage Immunotherapy. Advanced Materials. 32(24). e2000648–e2000648. 85 indexed citations
10.
Ramesh, Anujan, Siva Kumar Natarajan, Dipika Nandi, & Ashish Kulkarni. (2019). Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor. Cellular and Molecular Bioengineering. 12(5). 357–373. 12 indexed citations
11.
Ramesh, Anujan, et al.. (2019). Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy. Biomaterials. 227. 119559–119559. 76 indexed citations
12.
Ramesh, Anujan, Sahana Kumar, Dipika Nandi, & Ashish Kulkarni. (2019). CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages. Advanced Materials. 31(51). e1904364–e1904364. 162 indexed citations
13.
Ojha, Amrita, Dipika Nandi, Rashi Singhal, et al.. (2017). Platelet activation determines the severity of thrombocytopenia in dengue infection. Scientific Reports. 7(1). 41697–41697. 141 indexed citations
14.
Telfer, Janice C., et al.. (2017). WC1 is a hybrid gammadelta TCR coreceptor and pattern recognition receptor for pathogenic bacteria. The Journal of Immunology. 198(Supplement_1). 226.19–226.19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026